Lordi

06.12.2017 , 17:26 Uhr

Ich halte deine Aussagen für gefährlich, weil die Langzeitstudien über Antidepressiva sehr eindeutig sind:

Den psychopharmakologisch geht es langfristig durchschnittlich schlechter als der unbehandelten Placebogruppe, und zwar nicht nur in Bezug auf "Symptome", sondern auch in Lebensqualität, Suzidalität, Partnerschaft, Beruf, etc.

Das ist auch verständlich, wenn man die Wirkweise der Psychopharmaka betrachtet. Wie Drogen wirken sie auf Synapsen im Gehirn, das Gehirn passt sich an diese Wirkung an ("Homöostase") und dadurch lässt die Wirkung nach, die Nebenwirkungen bleiben jedoch bestehen :(

Dazu nur ein paar beispielhafte Studien zitiert aus dem Buch "Anatomy of an Epidemic" von Robert Whitaker:

________

1990: In a large, national depression study, the eighteen-month stay-well rate was highest for those treated with psychotherapy (30 percent) and lowest for those treated with an antidepressant (19 percent). (NIMH)

1995: In a six-year study of 547 depressed patients, those who were treated for the disorder were nearly seven times more likely to become incapacitated than those who weren’t, and three times more likely to suffer a “cessation” of their “principal social role.” (NIMH)

1998: In a World Health Organization study of the merits of screening for depression, those diagnosed and treated with psychiatric medications fared worse—in terms of their depressive symptoms and their general health—over a one-year period than those who weren’t exposed to the drugs. (WHO)

2001: In a study of 1,281 Canadians who went on short-term disability for depression, 19 percent of those who took an antidepressant ended up on long-term disability, versus 9 percent of those who didn’t take the medication. (Canadian investigators)

2005: In a five-year study of 9,508 depressed patients, those who took an antidepressant were, on average, symptomatic nineteen weeks a year, versus eleven weeks for those who didn’t take any medication. (University of Calgary)

________